Combined analysis of AFP and HCCR-1 as an useful serological marker for small hepatocellular carcinoma: A prospective cohort study

Disease Markers

Volumn 32, Issue 4, 2012, Pages 265-271

  Zhang, Guoxin ^a   Ha, Seon Ah ^b   Kim, Hyun K ^b   Yoo, Jinah ^b   Kim, Sanghee ^b   Lee, Youn S ^b   Hur, Soo Y ^b   Kim, Yong W ^b   Kim, Tae E ^b   Park, Yong G ^b   Wang, Jing ^a   Yang, Yang ^a   Xu, Zekuan ^a   Song, Eun Y ^c   Huang, Zuhu ^a   Jirun, Peng ^d   Zhongtian, Jin ^d   Shishi, Qiao ^d   Zhuqingqing, Cui ^d   Lei, Gong ^d   Kim, Jin W ^b   more..

^a NANJING MEDICAL UNIVERSITY   (China)

^b The Catholic University of Korea   (South Korea)

^c Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^d PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

Author keywords

AFP; biomarker; HCCR 1; Hepatocellular carcinoma

Indexed keywords

ALPHA FETOPROTEIN; HUMAN CERVICAL CANCER PROTO ONCOPROTEIN 1; ONCOPROTEIN; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER SIZE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; EARLY DIAGNOSIS; FEMALE; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY;

EID: 84859329140     PISSN: 02780240     EISSN: 18758630     Source Type: Journal    
DOI: 10.3233/DMA-2011-0878     Document Type: Article

References (23)

1. D.M. Parkin, F. Bray, J. Ferlay and P. Pisani, Estimating the world cancer burden: Globocan 2000, Int J Cancer 94 (2001), 153-156. (Pubitemid 32911406)
2. L. Zhou, J. Liu and F. Luo, Serum tumor markers for detection of hepatocellular carcinoma. World J Gastroenterol 12(8) (2006), 1175-1181.
3. J. Bruix, M. Sherman, J.M. Llovet et al., EASL Panel of Experts on HCC: Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver, J Hepatol 35 (2001), 421-430. (Pubitemid 32844200)
4. J.C. Sheu, J.L. Sung, D.S. Chen et al., Early detection of hepatocellular carcinoma by real-time ultrasonography. A prospective study, Cancer 56 (1985) 660-666.
5. P. Stefaniuk, J. Cianciara and A.Wiercinska-Drapalo, Present and future possibilities for early diagnosis of hepatocellular carcinoma, World J Gastroenterol 16(4) (2010), 418-424.
6. M. Soresi, C. Magliarisi, P. Campagna et al., Usefulness of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma, Anticancer Res 23 (2003), 1747-1753. (Pubitemid 36750842)
7. S.K. Yoon, N.K. Lim, S-A. Ha et al., The human cervical cancer oncogene protein is a biomarker for human hepatocellular carcinoma, Cancer Res 64 (2004), 5434-5441. (Pubitemid 39006566)
8. D. Geng, J. Chen and L. Chen, Effect of matrine on expression of HCCR-1 and HCCR-2 proteins in cultural human hepatocellular carcinomas cells, Chinese J Cancer Res 17(4) (2005), 265-269. (Pubitemid 43074934)
9. J.B. Xia, Z.H. Zhang, Y.J. Tian et al., Cloning, prokaryotic expression and polyclonal antibody preparation of HCCR-1: a new biomarker for hepatocellular carcinoma, Zhonghua Gan Zang Bing Za Zhi 14(2) (2006), 101-104.
10. Y. Yang, G.X. Zhang, R.H. Shi et al., Overexpression of HCCR-1 in hepatocellular carcinoma cells and its clinical significance, Zhonghua Gan Zang Bing Za Zhi 15(3) (2007), 223-224.
11. J Ko, Y.H. Lee, S.Y. Hwang et al., Identification and differential expression of novel human cervical cancer oncogene HCCR-2 in human cancers and its involvement in p53 stabilization, Oncogene 22 (2003), 4679-4689. (Pubitemid 36976443)
12. J. Ko, S.M. Shin, Y.M. Oh et al., Transgenic mouse model for breast cancer: induction of breast cancer in novel oncogene HCCR-2 transgenic mice, Oncogene 23 (2004), 1950-1953. (Pubitemid 38445421)
13. G.W. Cho, S.M. Shin, H. Namkoong et al., The phosphatidylinositol 3-kinase/Akt pathway regulates the HCCR-1 oncogene expression, Gene 384 (2006), 18-26. (Pubitemid 44738325)
14. F.X. Bosch, J. Ribes, R. Cleries and M. Diaz, Epidemiology of hepatocellular carcinoma, Clin Liver Dis 9 (2005), 191-211.
15. C. Verhoef, O. Visser, R.A. de Man et al., Hepatocellular carcinoma in the Netherlands incidence, treatment and survival patterns, Eur J Cancer 40 (2004), 1530-1538. (Pubitemid 38757741)
16. M.A. Avila, C. Berasain, B. Sangro and J. Prieto, New therapies for hepatocellular carcinoma, Oncogene 25 (2006), 3866-3884. (Pubitemid 43980482)
17. P.J. Johnson, R. Williams, H. Thomas et al., Induction of remission in hepatocellular carcinoma with doxorubicin, Lancet 1 (1978), 1006-1009. (Pubitemid 8342858)
18. G.I. Abelev, S.D. Perova, N.I. Khramkova et al., Production of embryonal alpha-globulin by transplantable mouse hepatomas, Transplantation 1 (1963), 174-180.
19. S. Gupta, S. Bent and J.Kohlwes, Test characteristics of alpha-fetoprotein for detecting hepatocellular carcinoma in patients with hepatitis C. A systematic review and critical analysis, Ann Intern Med 139 (2003), 46-50. (Pubitemid 38124619)
20. C.N. Yeh, W.C. Lee and M.F. Chen, Hepatic resection and prognosis for patients with hepatocellular carcinoma larger than 10 cm: two decades of experience at Chang Gung memorial hospital, Ann Surg Oncol 10 (2003), 1070-1076.
21. C.B. O'Suilleabhain, R.T. Poon, J.L. Yong et al., Factors predictive of 5-year survival after transarterial chemoembolization for inoperable hepatocellular carcinoma, Br J Surg 90 (2003), 325-331. (Pubitemid 36324112)
22. P.J. Johnson and R. Williams, Serum alpha-fetoprotein estimations and doubling time in hepatocellular carcinoma: Influence of therapy and possible value in early detection, J Nat Cancer Inst 64 (1980), 1329-1332. (Pubitemid 10109725)
23. P.J. Johnson, The Role of Serum Alpha-fetoprotein Estimation in the Diagnosis and Management of Hepatocellular Carcinoma, in: Clinics in Liver Disease, A. Di Bisceglie, ed., WB Saunders, Philadelphia, 2001, pp. 145-159. (Pubitemid 32118643)